InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+20.0%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Lang James Paul, Director. Insider active across 2 companies, notably OptimizeRx Corp. In total, 10 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €2.3m. Activity tracked since 30 June 2021. The latest transaction was filed on 14 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
321,408 shares@ US$7.603395.8% of flowCommon StockSEC:0001628280-25-013918:0
Ideal exit: 9 Dec 2025 (T+270)
10,061 shares0Common StockSEC:0001628280-24-027709:0
4,637 shares0Common StockSEC:0001628280-23-029928:0
657 shares0Common StockSEC:0001628280-23-010323:0
43,578 shares0COMMON STOCKSEC:0001520138-23-000059:0
409 shares0Common StockSEC:0001628280-23-000210:0
334 shares0Common StockSEC:0001628280-22-025811:0
6,000 shares@ US$16.45394.2% of flowCommon StockSEC:0001213900-22-050556:0
Ideal exit: 16 May 2023 (T+270)
407 shares0Common StockSEC:0001213900-21-035078
407 shares0Common StockSEC:0001213900-21-035078:0
10 of 10 declarations
About Lang James Paul
Lang James Paul is a Board Member at OptimizeRx Corp. In this role, he participates in the governance of the company and the development of its strategy. His experience in the technology sector allows him to make significant contributions to board discussions. He is committed to supporting OptimizeRx's growth objectives.
